87 related articles for article (PubMed ID: 29698702)
41. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
[TBL] [Abstract][Full Text] [Related]
42. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
43. Site-Specific Linking of an Oligonucleotide to Mono- and Bivalent Recombinant Antibodies with SpyCatcher-SpyTag System for Immuno-PCR.
Kushnarova-Vakal A; Äärelä A; Huovinen T; Virta P; Lamminmäki U
ACS Omega; 2020 Sep; 5(38):24927-24934. PubMed ID: 33015512
[TBL] [Abstract][Full Text] [Related]
44. A VAR2CSA:CSP conjugate capable of inducing dual specificity antibody responses.
Sungwa M; Susan T; Mikkel JC; Adolph KR; Boniface MS; Grundtvig TT; Ali S; Agertoug NM; Frederik SA
Afr Health Sci; 2017 Jun; 17(2):373-381. PubMed ID: 29062332
[TBL] [Abstract][Full Text] [Related]
45. Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.
Kim YJ; Bae J; Shin TH; Kang SH; Jeong M; Han Y; Park JH; Kim SK; Kim YS
J Control Release; 2015 Oct; 216():56-68. PubMed ID: 26260451
[TBL] [Abstract][Full Text] [Related]
46. NHS76/PEP2, a fully human vasopermeability-enhancing agent to increase the uptake and efficacy of cancer chemotherapy.
Khawli LA; Hu P; Epstein AL
Clin Cancer Res; 2005 Apr; 11(8):3084-93. PubMed ID: 15837764
[TBL] [Abstract][Full Text] [Related]
47. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
[TBL] [Abstract][Full Text] [Related]
48. Docetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy.
Yoon HY; Kwak SS; Jang MH; Kang MH; Sung SW; Kim CH; Kim SR; Yeom DW; Kang MJ; Choi YW
Int J Pharm; 2017 May; 523(1):229-237. PubMed ID: 28341149
[TBL] [Abstract][Full Text] [Related]
49. SpyTag/SpyCatcher molecular cyclization confers protein stability and resilience to aggregation.
Sun XB; Cao JW; Wang JK; Lin HZ; Gao DY; Qian GY; Park YD; Chen ZF; Wang Q
N Biotechnol; 2019 Mar; 49():28-36. PubMed ID: 30572026
[TBL] [Abstract][Full Text] [Related]
50. [Inhibitory effect of recombinant anti-angiogenic peptide of tumstatin on growth and metastasis of human ovarian cancer transplanted in nude mice].
Zhang GM; Sui LH; Jia T; Zhao YZ; Fu SB; Liu XH; Yu Y
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):170-3. PubMed ID: 18756929
[TBL] [Abstract][Full Text] [Related]
51. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
[TBL] [Abstract][Full Text] [Related]
52. Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy.
Fujimoto-Ouchi K; Sekiguchi F; Yamamoto K; Shirane M; Yamashita Y; Mori K
Cancer Chemother Pharmacol; 2010 Jul; 66(2):269-76. PubMed ID: 19904537
[TBL] [Abstract][Full Text] [Related]
53. In vivo targeting of c-Met using a non-standard macrocyclic peptide in gastric carcinoma.
Hwang DW; Bahng N; Ito K; Ha S; Kim MY; Lee E; Suga H; Lee DS
Cancer Lett; 2017 Jan; 385():144-149. PubMed ID: 27810404
[TBL] [Abstract][Full Text] [Related]
54. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
55. Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased
Feng J; Zhao C; Wang L; Qu L; Zhu H; Yang Z; An G; Tian H; Shou C
Theranostics; 2018; 8(8):2094-2106. PubMed ID: 29721065
[TBL] [Abstract][Full Text] [Related]
56. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
57. Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release and enhancement of anti-tumor activity in vivo.
Gaowa A; Horibe T; Kohno M; Sato K; Harada H; Hiraoka M; Tabata Y; Kawakami K
J Control Release; 2014 Feb; 176():1-7. PubMed ID: 24378440
[TBL] [Abstract][Full Text] [Related]
58. Enhancing the stability of trehalose synthase via SpyTag/SpyCatcher cyclization to improve its performance in industrial biocatalysts.
Xu C; Xu Q; Huang H; Jiang L
Biosci Biotechnol Biochem; 2018 Sep; 82(9):1473-1479. PubMed ID: 29804511
[TBL] [Abstract][Full Text] [Related]
59. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
60. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
